메뉴 건너뛰기




Volumn 14, Issue 3, 2009, Pages 411-418

Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies

Author keywords

Bacteremia; Children; Febrile neutropenia; Malignancies; Risk stratification

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN;

EID: 70350050231     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (6)

References (36)
  • 1
    • 0024245572 scopus 로고
    • The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation
    • Talcott JA, Finberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med 1988; 148: 2561-2568.
    • (1988) Arch Intern Med , vol.148 , pp. 2561-2568
    • Talcott, J.A.1    Finberg, R.2    Mayer, R.J.3    Goldman, L.4
  • 3
    • 0030701941 scopus 로고    scopus 로고
    • A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies
    • International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organisation for Research and Treatment of Cancer (EORTC)
    • Hann I, Viscoli C, Paesmans M et al. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organisation for Research and Treatment of Cancer (EORTC). Br J Haematol 1997; 99: 580-588.
    • (1997) Br J Haematol , vol.99 , pp. 580-588
    • Hann, I.1    Viscoli, C.2    Paesmans, M.3
  • 4
    • 0033614926 scopus 로고    scopus 로고
    • Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy
    • for the International Antimicrobial Therapy Cooperative Group of the European Organisation for Research and Treatment of Cancer
    • Kern WV, Cometta A, deBock R et al, for the International Antimicrobial Therapy Cooperative Group of the European Organisation for Research and Treatment of Cancer. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999; 341: 312-318.
    • (1999) N Engl J Med , vol.341 , pp. 312-318
    • Kern, W.V.1    Cometta, A.2    DeBock, R.3
  • 5
    • 70350060244 scopus 로고    scopus 로고
    • Low-risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care?
    • Ammann RA, Simon A, De Bont E. Low-risk episodes of fever and neutropenia in pediatric oncology: is outpatient oral antibiotic therapy the new gold standard of care? Pediatr Blood Cancer 2005; 44: 1-4.
    • (2005) Pediatr Blood Cancer , vol.44 , pp. 1-4
    • Ammann, R.A.1    Simon, A.2    De Bont, E.3
  • 7
    • 0034004453 scopus 로고    scopus 로고
    • "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia
    • Klaassen RJ, Goodman TR, Pham B, Doyle JJ. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 2000; 18: 1012-1019.
    • (2000) J Clin Oncol , vol.18 , pp. 1012-1019
    • Klaassen, R.J.1    Goodman, T.R.2    Pham, B.3    Doyle, J.J.4
  • 8
    • 0037439502 scopus 로고    scopus 로고
    • Epidemiology and risk factors for gram-positive coccal infections in neutropenia: Toward a more targeted antibiotic strategy
    • Cordonnier C, Buzyn A, Leverger G et al. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 2003; 36: 149-158.
    • (2003) Clin Infect Dis , vol.36 , pp. 149-158
    • Cordonnier, C.1    Buzyn, A.2    Leverger, G.3
  • 9
    • 0035189156 scopus 로고    scopus 로고
    • Empiric antibiotic prescribing practice in febrile neutropenia: Compliance with IDSA guidelines
    • Newman J, Thompson C, Hussain Z, Bombassaro AM. Empiric antibiotic prescribing practice in febrile neutropenia: compliance with IDSA guidelines. Can J Hosp Pharm 2001; 54: 255-263. (Pubitemid 33094819)
    • (2001) Canadian Journal of Hospital Pharmacy , vol.54 , Issue.4 , pp. 255-263
    • Newman, J.1    Thompson, C.2    Hussain, Z.3    Bombassaro, A.M.4
  • 10
    • 0036166325 scopus 로고    scopus 로고
    • Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer
    • DOI 10.1007/s15010-002-2094-1
    • Lehrnbecher T, Stanescu A, Kuhl J. Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer. Infection 2002; 30: 17-21. (Pubitemid 34146407)
    • (2002) Infection , vol.30 , Issue.1 , pp. 17-21
    • Lehrnbecher, T.1    Stanescu, A.2    Kuhl, J.3
  • 11
    • 0142062516 scopus 로고    scopus 로고
    • Antimicrobial therapy of unexplained fever in neutropenic patients
    • Link H, Bohme A, Cornely OA et al. Antimicrobial therapy of unexplained fever in neutropenic patients. Ann Hematol 2003; 82 (Suppl 2): S105-S117.
    • (2003) Ann Hematol , vol.82 , Issue.SUPPL. 2
    • Link, H.1    Bohme, A.2    Cornely, O.A.3
  • 12
    • 0026553534 scopus 로고
    • Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia
    • Heney D, Lewis IJ, Evans SW et al. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis 1992; 165: 886-890.
    • (1992) J Infect Dis , vol.165 , pp. 886-890
    • Heney, D.1    Lewis, I.J.2    Evans, S.W.3
  • 13
    • 0041386234 scopus 로고    scopus 로고
    • Treatment of febrile neutropenic patients with cancer who require hospitalization
    • Raad II, Escalante C, Hachem RY et al. Treatment of febrile neutropenic patients with cancer who require hospitalization. Cancer 2003; 98: 1039-1047.
    • (2003) Cancer , vol.98 , pp. 1039-1047
    • Raad, I.I.1    Escalante, C.2    Hachem, R.Y.3
  • 14
    • 0036943053 scopus 로고    scopus 로고
    • Outcomes and costs of febrile neutropenia: Adventures in the science and art of treatment choices
    • Elting LS, Cantor SB. Outcomes and costs of febrile neutropenia: adventures in the science and art of treatment choices. Support Care Cancer 2002; 10: 189-196.
    • (2002) Support Care Cancer , vol.10 , pp. 189-196
    • Elting, L.S.1    Cantor, S.B.2
  • 16
    • 0028270891 scopus 로고
    • Factors associated with bacteraemia in febrile, granulocytopenic cancer patients
    • Viscoli C, Bruzzi P, Castagnola E et al. Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. Eur J Cancer 1994; 30A: 430-437.
    • (1994) Eur J Cancer , vol.30 A , pp. 430-437
    • Viscoli, C.1    Bruzzi, P.2    Castagnola, E.3
  • 17
    • 0030873259 scopus 로고    scopus 로고
    • Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: A prospective study
    • Santolaya ME, Villarroel M, Avendano LF, Cofre J. Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study. Clin Infect Dis 1997; 25: 92-97. (Pubitemid 27293081)
    • (1997) Clinical Infectious Diseases , vol.25 , Issue.1 , pp. 92-97
    • Santolaya, M.E.1    Villarroel, M.2    Avendano, L.F.3    Cofre, J.4
  • 18
    • 0033731128 scopus 로고    scopus 로고
    • Clinical and laboratory features predicting a favorable outcome and allowing early discharge in cancer patients with low-risk febrile neutropenia: A literature review
    • DOI 10.1089/15258160050196687
    • Castagnola E, Paola D, Giacchino R, Viscoli C. Clinical and laboratory features predicting a favourable outcome and allowing early discharge in cancer patients with low-risk febrile neutropenia: a literature review. J Hematother Stem Cell Res 2000; 9: 645-649. (Pubitemid 30848399)
    • (2000) Journal of Hematotherapy and Stem Cell Research , vol.9 , Issue.5 , pp. 645-649
    • Castagnola, E.1    Paola, D.2    Giacchino, R.3    Viscoli, C.4
  • 20
    • 0346638603 scopus 로고    scopus 로고
    • Identifying neutropenic febrile cancer patients at risk for early death
    • Wilbur DW, Rentschler RE, Couperas JJ et al. Identifying neutropenic febrile cancer patients at risk for early death. Infect Med 2000; 17: 347-354.
    • (2000) Infect Med , vol.17 , pp. 347-354
    • Wilbur, D.W.1    Rentschler, R.E.2    Couperas, J.J.3
  • 21
    • 0141960348 scopus 로고    scopus 로고
    • Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection
    • DOI 10.1002/mpo.10320
    • Ammann RA, Hirt A, Luthy AR, Aebi C. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol 2003; 41: 436-443. (Pubitemid 37229435)
    • (2003) Medical and Pediatric Oncology , vol.41 , Issue.5 , pp. 436-443
    • Ammann, R.A.1    Hirt, A.2    Luthy, A.R.3    Aebi, C.4
  • 22
    • 0031749504 scopus 로고    scopus 로고
    • The evolution of the empirical management of fever and neutropenia in cancer patients
    • Viscoli C. The evolution of the empirical management of fever and neutropenia in cancer patients. J Antimicrob Chemother 1998; 41 (Suppl D): 65-80. (Pubitemid 28284508)
    • (1998) Journal of Antimicrobial Chemotherapy , vol.41 , Issue.SUPPL. D , pp. 65-80
    • Viscoli, C.1
  • 23
    • 0030020780 scopus 로고    scopus 로고
    • The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis
    • DOI 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2- V
    • Lucas KG, Brown AE, Armstrong D et al. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 1996; 77: 791-798. (Pubitemid 26055407)
    • (1996) Cancer , vol.77 , Issue.4 , pp. 791-798
    • Lucas, K.G.1    Brown, A.E.2    Armstrong, D.3    Chapman, D.4    Heller, G.5
  • 24
    • 0842347666 scopus 로고    scopus 로고
    • Predicting bacteremia in children with fever and chemotherapy-induced neutropenia
    • DOI 10.1097/01.inf.0000106782.30100.4f
    • Ammann RA, Hirt A, Luthy AR, Aebi C. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis 2004; 23: 61-67. (Pubitemid 38176764)
    • (2004) Pediatric Infectious Disease Journal , vol.23 , Issue.1 , pp. 61-67
    • Ammann, R.A.1    Hirt, A.2    Luthy, A.R.3    Aebi, C.4
  • 25
    • 0036328732 scopus 로고    scopus 로고
    • Treatment of febrile neutropenia: What is new?
    • Viscoli C, Castagnola E. Treatment of febrile neutropenia: what is new? Curr Opin Infect Dis 2002; 15: 377-382.
    • (2002) Curr Opin Infect Dis , vol.15 , pp. 377-382
    • Viscoli, C.1    Castagnola, E.2
  • 27
    • 0033771464 scopus 로고    scopus 로고
    • Unusual presentations of infection in neutropenic patients
    • Bodey GP. Unusual presentations of infection in neutropenic patients. Int J Antimicrob Agents 2000; 16: 93-95.
    • (2000) Int J Antimicrob Agents , vol.16 , pp. 93-95
    • Bodey, G.P.1
  • 28
    • 0028266346 scopus 로고
    • C-reactive protein: A valuable aid for the management of febrile children with cancer and neutropenia
    • Santolaya ME, Cofre J, Beresi V. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia. Clin Infect Dis 1994; 18: 589-595. (Pubitemid 24106912)
    • (1994) Clinical Infectious Diseases , vol.18 , Issue.4 , pp. 589-595
    • Santolaya, M.E.1    Cofre, J.2    Beresi, V.3
  • 29
    • 0029021519 scopus 로고
    • Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever
    • Engervall P, Granstrom M, Andersson B, Bjorkholm M. Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever. Eur J Haematol 1995; 54: 226-234.
    • (1995) Eur J Haematol , vol.54 , pp. 226-234
    • Engervall, P.1    Granstrom, M.2    Andersson, B.3    Bjorkholm, M.4
  • 30
    • 0032813989 scopus 로고    scopus 로고
    • Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and Mannose-binding protein in febrile children with cancer and neutropenia
    • Lehrnbecher T, Venzon D, de Haas M et al. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis 1999; 29: 414-419. (Pubitemid 29380209)
    • (1999) Clinical Infectious Diseases , vol.29 , Issue.2 , pp. 414-419
    • Lehrnbecher, Th.1    Venzon, D.2    De Haas, M.3    Chanock, S.J.4    Kuhl, J.5
  • 31
    • 3442898259 scopus 로고    scopus 로고
    • Measurement of C-reative protein in adults with febrile neutropenia after hematopoietic cell transplantation
    • DOI 10.1038/sj.bmt.1704409
    • Ortega M, Rovira M, Almela M et al. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation. Bone Marrow Transplant 2004; 33: 741-744. (Pubitemid 38499929)
    • (2004) Bone Marrow Transplantation , vol.33 , Issue.7 , pp. 741-744
    • Ortega, M.1    Rovira, M.2    Almela, M.3    De La Bellacasa, J.P.4    Carreras, E.5    Mensa, J.6
  • 32
    • 0029011297 scopus 로고
    • A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia
    • Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis 1995; 21: 114-121.
    • (1995) Clin Infect Dis , vol.21 , pp. 114-121
    • Manian, F.A.1
  • 33
    • 0035880643 scopus 로고    scopus 로고
    • Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia
    • Baorto EP, Aquino VM, Mullen CA et al. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer 2001; 92: 909-913.
    • (2001) Cancer , vol.92 , pp. 909-913
    • Baorto, E.P.1    Aquino, V.M.2    Mullen, C.A.3
  • 34
    • 0036255288 scopus 로고    scopus 로고
    • Value of electronic data for model validation and refinement: Bacteremia risk in children with fever and neutropenia
    • DOI 10.1097/00043426-200205000-00008
    • Madsen K, Rosenman M, Hui S, Breitfeld PP. Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia. J Pediatr Hematol Oncol 2002; 24: 256-262. (Pubitemid 34506611)
    • (2002) Journal of Pediatric Hematology/Oncology , vol.24 , Issue.4 , pp. 256-262
    • Madsen, K.1    Rosenman, M.2    Hui, S.3    Breitfeld, P.P.4
  • 35
    • 0036156259 scopus 로고    scopus 로고
    • Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer
    • Alexander SW, Wade KC, Hibberd PL, Parsons SK. Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 2002; 24: 38-42.
    • (2002) J Pediatr Hematol Oncol , vol.24 , pp. 38-42
    • Alexander, S.W.1    Wade, K.C.2    Hibberd, P.L.3    Parsons, S.K.4
  • 36
    • 0033776091 scopus 로고    scopus 로고
    • Risk factors assessment in febrile neutropenia
    • Paesmans M. Risk factors assessment in febrile neutropenia. Int J Antimicrob Agents 2000; 16: 107-111.
    • (2000) Int J Antimicrob Agents , vol.16 , pp. 107-111
    • Paesmans, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.